Genentech’s Post

At Belharra, we’re screening our proprietary library of diverse non-covalent chemical probes against a wide array of proteins implicated in serious diseases. We capture insights on these interactions using our advanced chemoproteomics platform and sophisticated informatics to aid in the identification of probes that can bind to proteins that are currently undruggable. With each screen, we add significantly to our data set of probe-protein interactions, creating a massive amount of high-quality data that could be a powerful learning set for AI or machine learning tools. In the latest episode of our #BirthOfABiotech podcast, we consider how these emerging technologies could support the rapid identification of small molecule therapies that bind to high-impact target proteins. Listen to the full episode to find out more! https://lnkd.in/d9424eZP #podcast #biotech #chemoproteomics #companyformation #companybuilding #futureofhealthcare #artificialintelligence #AI #machinelearning 

A great listen! @Jason Park discusses the @Empress approach to small molecule #drugdiscovery.

Our latest episode of the Alldus, “AI in Action” Podcast features Drew Linsley from Operant Biopharma. Here Drew talks us through his journey and how Operant are using AI to autonomously design biological experiments, discovering and optimizing disease treatments. It’s another example of the groundbreaking work across the AI world. If you are a business leader doing innovative work in AI and would be interested in featuring on the podcast, we’d love to hear from you. #biopharma #artificialintelligence #aiinaction

You may not like it… but there is a time when humans need to let the machines do the heavy lifting. We think there is a false dichotomy between humans doing the work and machines doing the work. Humans do better work with machines to enable them. But in conducting biotech experiments at scale, what is the role of seasoned human expertise versus artificial intelligence? AI can help speed up drug discovery, gene structure identification, condition diagnosis, and more. But sometimes, the biological processes' complexity is so immense that humans can miss the forest from the trees. Or - in practical terms - scientists can miss out on new innovations when they rely on human intuition alone. But on the other hand, ignoring decades of human experience can lead to costly mistakes. How do we strike the right balance? As Markus Gershater from Synthace points out on our podcast, it's about deeply understanding the specifics of the process that you're trying to solve. Only then do you know when to step back and let AI take the wheel… …and when to combine the strength of both human intelligence and machines. Only by embracing a hybrid approach can you maximize the potential of generating richer insights and achieving results faster. Want to listen to the full episode? Search for 'Data in Biotech' in your podcast platform of choice. — Do you have thoughts on the role of the scientist vs. AI in accelerating innovation in biotech? Drop them below, and maybe we can get you on the podcast to discuss it. #biotechnology #datascience

Turns out, when you ask the AI agent to “take the reins,” things get pretty interesting pretty quickly. https://lnkd.in/g5einQYg In this July edition of BCG’s CEO Digest podcast: Highlights of BCG’s latest thought leadership—and an unexpected insight into collaborating with AI.

Thanks, Daniel Levine, for this opportunity to talk about what makes Aulos Bioscience unique in our approach and how AU-007 is a promising therapeutic agent for cancer in the IL-2 space. What a great discussion, as always. #science #innovation

On the latest episode of Biotech Bytes Podcast, Elisabeth Schwartz, the IT Head at Phathom Pharmaceuticals, joined me to explore the crucial task of preparing data for AI applications and the hurdles we face in ensuring its reliability. Elisabeth brings a wealth of firsthand experience to the table, having navigated the intricate intersection of data and AI in biotech. She offers practical advice that industry professionals can use to fine-tune their data for optimal AI utilization. So, don't miss out! Tune in, grab those industry insights, and let's stay ahead in the fast-evolving landscape of technology. 👉 https://buff.ly/42uCZdi #podcast #pharma #biotech #aiapplications #datamanagement #data #ai #technology #IT

**NEW PODCAST** 🎙 Start off your Friday by checking out today's brand new episode in our AI in Action series of The Alldus Podcast as host JP Valentine chats with Nikolaus Obholzer, Director of Computational Biology at Kronos Bio. In the episode, Nikolaus will talk about: - The interesting work Kronos Bio are doing in the Biotech space - How they are utilizing Machine Learning - His responsibilities and how the team has evolved - What the near future looks like for Kronos Bio - Why Kronos Bio is a great place to work 🎧 Listen now at https://lnkd.in/emNS8U2r or subscribe & listen wherever you get your favorite podcasts #aiinaction #ai #artificialintelligence #machinelearning #computationalbiology #drugdiscovery #biotechnology #technology #innovation #podcast #allduspodcast

🎙️ Juan Piacquadio, MBA, MSIT briefly sums up the advantages brought by the introduction of digital twins, AI, and augmented reality to the pharmaceutical space. Listen to the full podcast on Claroty Nexus: https://hubs.li/Q02hWMPq0

Google's has released it's new Alphafold 3 AI model which outpaces it's predecessor, Alphafold 2. The new model can process DNA, RNA, and 'all life's molecules'. What does this mean for medical science, agriculture and other industries? Is this development underhyped given its potential impact on the future of society? Watch on YouTube: https://lnkd.in/gSWbU6Mc From the Briefly Creo Podcast - Tech Headlines, Episode 1 Recorded on 16 May 2024 Watch the full episode here: https://lnkd.in/gYp56yfr Watch or listen to the Briefly Creo Podcast on all platforms, including YouTube, Spotify, Apple Podcasts, and Audible. Find us on socials: @creolegalau Our website: https://creolegal.au #tech #auslaw #techlaw #techlawyer #AI #ailawyer #iplaw #iplawyer #intellectualproperty #openai #chatgpt #googleai #deepmind #googledeepmind #biomedicalresearch #bioscience #medicalscience #alphafold #alphafold3